FDA Guidance May Move Goalposts For Form 483 Responses
By Sonia Nath, Laura Akowuah and Auguste Humphries · April 8, 2026, 5:50 PM EDT
The U.S. Food and Drug Administration has issued new draft guidance giving drug manufacturers — for the first time — formal guidance on how the agency expects firms to respond to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login